Nanodiamond-based injectable hydrogel for sustained growth factor release: Preparation, characterization and in vitro analysis. (August 2017)

• Record Type: Journal Article
• Authors: Pacelli, Settimio; Acosta, Francisca; Chakravarti, Aparna R.; Samanta, Saheli G.; Whitlow, Jonathan; Modaresi, Saman; Ahmed, Rafeeq P.H.; Rajasingh, Johnson; Paul, Arghya
• Is Part Of: Acta biomaterialia. Volume 58(2017)
• Page Start: 479
• Page End: 491
• Publication Date: 2017-08
• Subjects: Injectable hydrogel -- Sustained release -- Nanocomposite hydrogel -- Nanomedicine -- Bioactive molecules; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2017.05.026
• Languages: English
• ISSNs: 1742-7061

Abstract

Graphical abstract: Abstract: Nanodiamonds (NDs) represent an emerging class of carbon nanomaterials that possess favorable physical and chemical properties to be used as multifunctional carriers for a variety of bioactive molecules. Here we report the synthesis and characterization of a new injectable ND-based nanocomposite hydrogel which facilitates a controlled release of therapeutic molecules for regenerative applications. In particular, we have formulated a thermosensitive hydrogel using gelatin, chitosan and NDs that provides a sustained release of exogenous human vascular endothelial growth factor (VEGF) for wound healing applications. Addition of NDs improved the mechanical properties of the injectable hydrogels without affecting its thermosensitive gelation properties. Biocompatibility of the generated hydrogel was verified by in vitro assessment of apoptotic gene expressions and anti-inflammatory interleukin productions. NDs were complexed with VEGF and the inclusion of this complex in the hydrogel network enabled the sustained release of the angiogenic growth factor. These results suggest for the first time that NDs can be used to formulate a biocompatible, thermosensitive and multifunctional hydrogel platform that can function both as a filling agent to modulate hydrogel properties, as well as a delivery platform for the controlled release of bioactive molecules and growth factors. Statement of Significance: One of the major drawbacks associated with the use of conventional hydrogels as carriers of growth factors is their inability to control the release kinetics of the loaded molecules. In fact, in most cases, a burst release is inevitable leading to diminished therapeutic effects and unsuccessful therapies. As a potential solution to this issue, we hereby propose a strategy of incorporating ND complexes within an injectable hydrogel matrix. The functional groups on the surface of the NDs can establish interactions with the model growth factor VEGF and promote a prolonged release from the polymer network, therefore, providing a longer therapeutic effect. Our strategy demonstrates the efficacy of using NDs as an essential component for the design of a novel injectable nanocomposite system with improved release capabilities.